• WCG’s eCOA portfolio and imaging analysis technology from NeuroRx are now part of Clario!

menu-close-icon
Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario Clario
  • Solutions
    • eCOA Clinical Trials
      • eCOA Clinical Trials
      • eCOA Live
      • eCOA Multimedia
      • eCOA Rapid Start
      • eCOA Rater and Participant Training
      • eCOA Rescue Studies
      • Suicidal Ideation
    • Artificial Intelligence (AI)

      Discover Clario's AI solutions, where innovation meets expertise. Since 2018, we have revolutionized clinical trial endpoint analyses with more than 30 AI-enabled solutions across 600+ active trials, enhancing data quality and patient privacy while expediting data collection processes.

      Go to page
    • Cardiac Solutions
      • Cardiac Solutions
      • Arrhythmia Analysis
      • Blood Pressure Services
      • ECG — On-site to DCT and Phase I-IV
      • Phase I/TQT Cardiac Assessment
      • Regulatory Consultation and Statistical Analysis Expertise
    • Medical Imaging
      • Medical Imaging
      • Medical Imaging science team
      • Image Redact AI
      • Imaging Platform
      • Modalities
      • SMART Submit
    • Precision Motion
      • Precision Motion for Clinical Trials
      • Precision Motion for Research
      • Precision Motion: Scientific Publications
    • Respiratory Solutions
      • Respiratory Solutions
      • Site-Based Spirometry (FEV1, FVC, PEF, and more.)
      • Virtual Home Spirometry
      • Cough and Lung Sounds
      • Diffusing Capacity (DLCO)
    • Trial Enablement
      • Trial Enablement
      • Clinical Adjudication
      • Eligibility Solution
      • Reporting & Analytics
      • Source Document Manager
    • Decentralized Trials

      All the precision endpoint technology and services your virtual or hybrid trial needs to deliver more certain outcomes.

      Go to page
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Neuroscience
    • Dermatology
    • Oncology
    • Gastroenterology
    • Ophthalmology
    • Hepatology
    • Respiratory Solutions
    • Infectious Diseases
    • Type 2 Diabetes and Obesity
    • Musculoskeletal
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Careers
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Newsroom
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Solutions
    • eCOA Clinical Trials
      • eCOA Clinical Trials
      • eCOA Live
      • eCOA Multimedia
      • eCOA Rapid Start
      • eCOA Rater and Participant Training
      • eCOA Rescue Studies
      • Suicidal Ideation
    • Artificial Intelligence (AI)
    • Cardiac Solutions
      • Cardiac Solutions
      • Arrhythmia Analysis
      • Blood Pressure Services
      • ECG — On-site to DCT and Phase I-IV
      • Phase I/TQT Cardiac Assessment
      • Regulatory Consultation and Statistical Analysis Expertise
    • Medical Imaging
      • Medical Imaging
      • Medical Imaging science team
      • Image Redact AI
      • Imaging Platform
      • Modalities
      • SMART Submit
    • Precision Motion
      • Precision Motion for Clinical Trials
      • Precision Motion for Research
      • Precision Motion: Scientific Publications
    • Respiratory Solutions
      • Respiratory Solutions
      • Site-Based Spirometry (FEV1, FVC, PEF, and more.)
      • Virtual Home Spirometry
      • Cough and Lung Sounds
      • Diffusing Capacity (DLCO)
    • Trial Enablement
      • Trial Enablement
      • Clinical Adjudication
      • Eligibility Solution
      • Reporting & Analytics
      • Source Document Manager
    • Decentralized Trials
      • Decentralized Trials
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
    • Oncology
    • Ophthalmology
    • Type 2 Diabetes and Obesity
    • Respiratory Solutions
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Contact sales
    • Log in
    • Contact sales
  1. Home Resources Downloads eCOA basics training course

eCOA basics training course

January 17, 2022

Course Introduction and Objective:

Welcome to Clario’s eCOA Basics course! Dive into 6 lessons that answer 3 basic questions:

  1. What is eCOA?
  2. Why use eCOA?
  3. When to use eCOA?

The overarching goal of this course is to equip you with a foundational understanding of electronic clinical outcome assessments (eCOA). We want you to be able to interpret and discuss when and why it is important to use eCOA in clinical trials.

Course Length:
Approximately 45 minutes, self-paced.

Assessment:
Includes knowledge checks within the material and a cumulative quiz for self-reflection.

Course Outline and Lesson Objectives:

Topic 1: What is eCOA?

1.1: What are COA and eCOA?

This content is beneficial to you if you desire to define COA and eCOA and understand the different types of COA and eCOA.

1.2: Technology Options for Implementing eCOA

This section identifies technology options for eCOA and explains scenarios in which they are typically implemented.

Topic 2: Why use eCOA?

2.1: Benefits for the Sponsor

This section dispels common myths you may have heard about using eCOA and outlines 5 key reasons why eCOA can improve data quality in clinical trials.

2.2: Benefits for Sites and Patients

This section outlines some advantages eCOA has over paper COA from the perspective of study site personnel and patients, and discusses why Patient-Reported Outcomes (PROs) are important to the patient.

2.3: Regulatory Perspective

This content is beneficial to you if you are interested in learning about eCOA recommendations from regulatory agencies, such as the FDA and EMA.

Topic 3: When to use eCOA?

3: When is it most critical to use eCOA?

Whether it is for better compliance, increased data accuracy, or a better user experience, this section outlines key scenarios when using eCOA is most critical.

Access the course

Latest Downloads

See all
Poster

Cognitive Assessment and Wearable Sensor-Based Gait and Balance Assessment in Studies of Alzheimer’s Disease and Mild Cognitive Impairment: A Preliminary Review

<!-- November 12, 2024 -->
Download icon Download icon
Download
Specification Sheet

OPAL V2R® technical specifications

<!-- May 21, 2024 -->
Download icon Download icon
Download
Datasheet

eCOA Zoom In/Zoom Out

<!-- May 7, 2024 -->
Download icon Download icon
Download
Poster

Optimal Digital Endpoint Selections of Movement in Parkinson’s disease

<!-- March 15, 2024 -->
Download icon Download icon
Download
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • Newsroom
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Contact sales

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below.


Not what you're looking for?

Please visit our Contact Page for customer support, office locations, or media contacts.

  • © 2025 Clario

    • Legal and Privacy Terms
    • Information Security
    • Cookie Policy
    • Impressum